1)日本小児血液・がん学会(編):小児血液・腫瘍学.pp549-552,診断と治療社,2015
2)Vermaete N, et al:Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy:a prospective longitudinal study. Ann Hematol 2014;93:411-424
3)Batchelor TT, et al:Steroid myopathy in cancer patients. Neurology 1997;48:1234-1238
4)Schakman O, et al:Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 2008;197:1-10
5)Gouspillou G, et al:Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle. Sci Rep 2015;5:8717
6)Bonifati DM, et al:Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents. Cancer Chemother Pharmacol 2000;46:517-522
7)澤村誠志,日本義肢装具学会(監):義肢学,第3版.pp82-88,医歯薬出版,2015
8)Van Moll CCA, et al:The effect of training during treatment with chemotherapy on muscle strength and endurance capacity:a systematic review. Acta Oncol 2016;55:539-546
9)Schmitz KH, et al:American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42:1409-1426
10)Bowen TS, et al:Skeletal muscle wasting in cachexia and sarcopenia:molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 2015;6:197-207
11)Fernandez-Pineda I, et al:Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas:a report from the St. Jude Lifetime Cohort Study. J Cancer Surviv 2017;11:1-12
12)Ginsberg JP, et al:A comparative analysis of functional outcomes in adolescents and young adults with lower-extremity bone sarcoma. Pediatr Blood Cancer 2007;49:964-969